Financhill
Back

BioXcel Therapeutics Vs. Palatin Technologies Industry Stock Comparison

Sell
31

BTAI
BioXcel Therapeutics

Last Price:
0.41
Seasonality Move:
80.92%
Sell
40

PTN
Palatin Technologies

Last Price:
0.88
Seasonality Move:
6.65%
Sell
31
BioXcel Therapeutics (BTAI) is a Sell

Is BioXcel Therapeutics a Buy, Sell or Hold?

  • The current BioXcel Therapeutics [BTAI] share price is $0.41. The Score for BTAI is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • BTAI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Palatin Technologies (PTN) is a Sell

Is Palatin Technologies a Buy, Sell or Hold?

  • The current Palatin Technologies [PTN] share price is $0.88. The Score for PTN is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • PTN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BTAI Stock Price Chart

What is BioXcel Therapeutics's stock price today?

  • The BioXcel Therapeutics share price today is $0.41
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BTAI is experiencing slight selling pressure.

PTN Stock Price Chart

What is Palatin Technologies's stock price today?

  • The Palatin Technologies share price today is $0.88
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTN is experiencing buying pressure, which is a positive indicator for future bullish movement.

BTAI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 38.8 Sell
Chaikin Money Flow: 24525 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.4 - 0.6) Sell
Bollinger Bands (100): (0.46 - 0.82) Sell

PTN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 38.72 Sell
Chaikin Money Flow: 174691 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.9 - 1.14) Sell
Bollinger Bands (100): (0.94 - 1.48) Sell

BTAI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.42 Sell
20-day SMA: 0.47 Sell
50-day SMA: 0.55 Sell
200-day SMA: 1.38 Sell
8-day EMA: 0.43 Sell
20-day EMA: 0.47 Sell
50-day EMA: 0.55 Sell
200-day EMA: 1.78 Sell

PTN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.91 Sell
20-day SMA: 0.98 Sell
50-day SMA: 1.03 Sell
200-day SMA: 1.54 Sell
8-day EMA: 0.92 Sell
20-day EMA: 0.98 Sell
50-day EMA: 1.07 Sell
200-day EMA: 1.56 Sell

BioXcel Therapeutics Earnings Growth & BTAI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.29 per share, and an increase next year of $0.21 per share.

Palatin Technologies Earnings Growth & PTN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.39 per share, and an increase next year of $0.85 per share.

BioXcel Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Palatin Technologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):